Possible modulatory role of nitric oxide in lung toxicity induced in rats by chronic administration of bleomycin

Chemotherapy

Volumn 48, Issue 4-5, 2002, Pages 244-251

  El Khatib, Aiman S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Bleomycin; Lung toxicity; Nitric oxide; Rats

Indexed keywords

ARGININE; BLEOMYCIN; DIPEPTIDYL CARBOXYPEPTIDASE; DRINKING WATER; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HYDROXYPROLINE; LIPID PEROXIDE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRITE; LIPID PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRINKING; DRUG EFFECT; DRUG TOXICITY; ENZYME ACTIVITY; LONG TERM EXPOSURE; LUNG PARENCHYMA; LUNG TOXICITY; LUNG WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; STATISTICAL ANALYSIS; STIMULATION; SYNTHESIS; TISSUE LEVEL; WEIGHT REDUCTION; DRUG MECHANISM; DRUG POTENTIATION; WEIGHT CHANGE;

EID: 0036906975     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000066767     Document Type: Article

References (46)

1. Ryrfeldt Å, Bannenberg G, Moldéus P: Free radicals and lung disease. Br Med Bull 1993;49:588-603.
2. Suntres ZE, Shek PN: Protective effect of liposomal α-tocopherol against bleomycin-induced lung injury. Biomed Environ Sci 1997;10:47-59.
3. Chandler DB: Possible mechanisms of bleomycin-induced fibrosis. Clin Chest Med 1990;11:21-30.
4. Ortiz LA, Lasky J, Hamilton RF Jr, Holian A, Hoyle GW, Banks W, Peschon JJ, Brody AR, Lungarella G, Friedman M: Expression of TNF and the necessity of TNF receptors in bleomycin-induced lung injury in mice. Exp Lung Res 1998;24:721-743.
5. Khalil N, Whitman C, Zuo L, Danielpour D, Greenberg A: Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest 1993;92:1812-1818.
6. O'Neil CA, Giri SN: Biochemical mechanisms for the attenuation of bleomycin-induced lung fibrosis by treatment with niacin in hamsters: The role of NAD and ATP. Exp Lung Res 1994;20:41-56.
7. Giri SN, Sharma AK, Hyde DM, Wild JS: Amelioration of bleomycin-induced lung fibrosis by treatment with the platelet activating factor receptor antagonist WEB 2086 in hamsters. Exp Lung Res 1995;21:287-307.
8. Parizada B, Werber MM, Nimrod A: Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic Res Commun 1991;15:297-301.
9. Habib MP, Lackey DL, Lantz RC, Sobonya RE, Grad R, Earnest DL, Bloom JW: Vitamin A pretreatment and bleomycin-induced rat lung injury. Res Commun Chem Pathol Pharmacol 1993;81:199-208.
10. Karam H, Hurbain-Kosmath I, Housset B: Antioxidant activity in alveolar epithelial type 2 cells of rats during the development of bleomycin injury. Cell Biol Toxicol 1998;14:13-22.
11. Gutteridge JM, Xiao-Chang F: Protection of iron-catalyzed free radical damage to DNA and lipids by copper (II)-bleomycin. Biochem Biophys Res Commun 1981;99:1354-1360.
12. Karam H, Hurbain-Kosmath I, Housset B: Direct toxic effect of bleomycin on alveolar type 2 cells. Toxicol Lett 1995;76:155-163.
13. Lazo JS, Merrill WW, Pham ET, Lynch TJ, McCallister JD, Ingbar DH: Bleomycin hydrolase activity in pulmonary cells. J Pharmacol Exp Ther 1984;231:583-588.
14. Blom-Muilwijk MC, Vriesendorp R, Veninga TS, Hofstra W, Sleyfer DT, Wieringa RA, Konings AW: Pulmonary toxicity after treatment with bleomycin alone or in combination with hyperoxia. Studies in the rat. Br J Anaesth 1988;60:91-97.
15. Mall G, Burkhardt A: Pulmonary toxicity of the combination of bleomycin and peplomycin: An experimental study in rats. Cancer Chemother Pharmacol 1991;28:357-360.
16. Coursin DP, Cihla HP: Non-lethal hyperoxic potentiation of lung disease in the rat following subcutaneous administration of bleomycin. Toxicology 1988;16:45-55.
17. Coursin DB, Cihla HP, Oberley TD: Exacerbation of tallysomycin toxicity in rats by concurrent exposure to sublethal hyperoxia. Toxicology 1989;55:225-237.
18. McLaughlin GE, Frank L: Effects of the 21-aminosteroid, U74389F, on bleomycin-induced pulmonary fibrosis in rats. Crit Care Med 1994;22:313-319.
19. Piguet PF, Van GY, Guo J: Heparin attenuates bleomycin- but not silica-induced pulmonary fibrosis in mice: Possible relationship with involvement of myofibroblasts in bleomycin-, and fibroblasts in silica-induced fibrosis. Int J Exp Pathol 1996;77:155-161.
20. Vane JR, Gryglewski RJ, Botting RM: The endothelial cell as a metabolic and endocrine organ. Trends Pharmacol Sci 1987;8:491-496.
21. Schroeder RA, Kuo PC: Nitric oxide: Physiology and pharmacology. Anesth Analg 1995;81: 1052-1059.
22. Orr FW, Adamson IY, Warner D, Leroyer V, Werner L, Shaughnessy S, Young L: The effects of oxygen radical-mediated pulmonary endothelial damage on cancer metastasis. Mol Cell Biochem 1988;84:189-198.
23. Mutsaers SE, Marshall RP, Goldsack NR, Laurent GJ, McAnulty RJ: Effect of endothelin receptor antagonists (BQ-485, Ro 47-0203) on collagen deposition during the development of bleomycin-induced pulmonary fibrosis in rats. Pulm Pharmacol Ther 1998;11:221-225.
24. Underwood DC, Osborn RR, Bochnowicz S, Webb EF, Rieman DJ, Lee JC, Romanic AM, Adams JL, Hay DW, Griswold DE: SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung. Am J Physiol Lung Cell Mol Physiol 2000;279:L895-L902.
25. Slosman DO, Polla BS, Donath A: 123I-MIBG pulmonary removal: A biochemical marker of minimal lung endothelial cell lesions. Eur J Nucl Med 1990;16:633-637.
26. Suntres ZE, Shek PN: Alleviation of paraquat-induced lung injury by pretreatment with bifunctional liposomes containing α-tocopherol and glutathione. Biochem Pharmacol 1996;52: 1515-1520.
27. Woessner JF Jr: The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 1961;93:440-447.
28. Griess JB: Ber Deutsch Chem Ges 1879;12: 426-429.
29. Holmquist B, Bunning P, Riordan JF: A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 1979;95: 540-548.
30. Paglia DE, Valentine WN: Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158-169.
31. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
32. Ellman G: Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-77.
33. Slosman DO, Costabella PM, Roth M, Werlen G, Polla BS: Bleomycin primes monocytes-macrophages for superoxide production. Eur Respir J 1990;3:772-778.
34. Newman RA, Kimberly PJ, Stewart JA, Kelley J: Assessment of bleomycin lung toxicity using angiotensin converting enzyme in pulmonary lavage. Cancer Res 1980;40:3621-3626.
35. Berend N: Protective effect of hypoxia on bleomycin lung toxicity in the rat. Am Rev Respir Dis 1984;130:307-308.
36. Reed DJ: Glutathione: Toxicological implications. Annu Rev Pharmacol Toxicol 1990;30: 603-631.
37. El-Khatib AS: Biologically active free radicals and their scavengers: A review. Saud Pharm J 1997;5:79-89.
38. Phan SH, Fantone JC: Inhibition of bleomycin-induced pulmonary fibrosis by lipopolysaccharide. Lab Invest 1984;50:587-591.
39. Muriel P: Nitric oxide protection of rat liver from lipid peroxidation, collagen accumulation, and liver damage induced by carbon tetrachloride. Biochem Pharmacol 1998;56:773-779.
40. Yang CW, Kim YS, Kim J, Kim YO, Min SY, Choi EJ, Bang BK: Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats. Exp Nephrol 1998;6:50-56.
41. G-nitro-L-arginine methyl ester on nephrotoxicity induced by gentamicin in rats. Nephron 1995;71:203-207.
42. Gardner MP, Houghton DC, Andoh TF, Lindsley J, Bennett WM: Clinically relevant doses and blood levels produce experimental cyclosporine nephrotoxicity when combined with nitric oxide inhibition. Transplantation 1996;61:1506-1512.
43. Peao MN, Aguas AP, de Sa CM, Grande NR: Neoformation of blood vessels in association with rat lung fibrosis induced by bleomycin. Anat Rec 1994;238:57-67.
44. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER: Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 1982;126:332-337.
45. Salvemini D, Botting R: Modulation of platelet function by free radicals and free radical scavengers. Trends Pharmacol Sci 1993;14:36-42.
46. Wu G, Meininger CJ: Arginine nutrition and cardiovascular function. J Nutr 2000;130: 2626-2629.